Michael G. Bator
CIK: 0001647591
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cytosorbents Corp
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 8, 2025CTSO
Cytosorbents Corp
Award(A)DirectStock Option (Right to Buy)
44K shares- - Feb 24, 2025CTSO
Cytosorbents Corp
Out-of-Term(O)Direct10K shares at avg. $1.13$11K - Jan 17, 2025CTSO
Cytosorbents Corp
In-the-Money(X)Direct15.9K shares at avg. $1.00$16K - Jan 17, 2025CTSO
Cytosorbents Corp
Other(J)DirectSeries A Right Warrants
15.9K shares- - Jan 17, 2025CTSO
Cytosorbents Corp
Other(J)DirectSeries B Right Warrants
15.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 8, 2025 | CTSO Cytosorbents Corp | Award(A) Stock Option (Right to Buy) | 44,000 | - | - | Direct |
| Feb 24, 2025 | CTSO Cytosorbents Corp | Out-of-Term(O) | 10,000 | $1.13 | $11,300 | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | In-the-Money(X) | 15,879 | $1.00 | $15,879 | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other(J) Series A Right Warrants | 15,879 | - | - | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other(J) Series B Right Warrants | 15,879 | - | - | Direct |
1-5 of 5 transactions
About BATOR MICHAEL G.
BATOR MICHAEL G. (SEC CIK 0001647591) files insider reports with the SEC as Director of Cytosorbents Corp (CTSO).
Signal8 holds 3 ownership filings by BATOR MICHAEL G., all Form 4s, filed between Jan 22, 2025 and Aug 8, 2025. Those filings report 5 transactions, from Jan 17, 2025 to Aug 8, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on BATOR MICHAEL G.'s filings is in PRINCETON, NJ.
Recent filings by BATOR MICHAEL G.
- Aug 8, 2025: Grant or award of CTSO derivative securities (Form 4, code A).
- Feb 24, 2025: Out-of-the-money exercise transaction of CTSO shares (Form 4, code O).
- Jan 17, 2025: Option exercise of CTSO shares (Form 4, code X).
- Jan 17, 2025: Other transactions of CTSO derivative securities (2 lines, Form 4, code J).
Other insiders filing for Cytosorbents Corp (CTSO)
- Chan Phillip P., Chief Executive Officer
- Capponi Vincent, President and COO
- Sobel Alan D., Director
- MARIANI PETER J, Chief Financial Officer
- Jones Edward Raymond, Director
- Kim Jiny, Director